Fractyl Health announced positive one-year results from its REVEAL-1 Cohort, reporting that patients who underwent the Revita procedure maintained approximately 78% of their prior GLP-1-induced weight loss. Additionally, 33% of participants continued to lose weight at the one-year mark, and 100% of patients maintained at least 5% of their drug-induced weight loss.
